Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)

Annelot G.J. Van Rossum, Ingrid A.M. Mandjes, Erik Van Werkhoven, Harm Van Tinteren, A. Elise Van Leeuwen-Stok, Petra Nederlof, Johanna E.A. Portielje, Robbert J. Van Alphen, Els Platte, Daan Van Den Broek, Alwin Huitema, Marleen Kok, Sabine C. Linn, Hendrika M. Oosterkamp

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Agricultural and Biological Sciences